Chesley Taft & Associates LLC Increases Position in Zoetis Inc. (NYSE:ZTS)

Chesley Taft & Associates LLC raised its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 1.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 111,003 shares of the company’s stock after buying an additional 1,471 shares during the period. Chesley Taft & Associates LLC’s holdings in Zoetis were worth $21,688,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the company. Price T Rowe Associates Inc. MD lifted its holdings in Zoetis by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock worth $2,707,262,000 after buying an additional 3,244,074 shares during the period. Global Assets Advisory LLC acquired a new position in shares of Zoetis in the 1st quarter valued at $8,831,000. Franklin Street Advisors Inc. NC increased its position in shares of Zoetis by 4.3% in the 1st quarter. Franklin Street Advisors Inc. NC now owns 121,024 shares of the company’s stock valued at $20,478,000 after acquiring an additional 5,035 shares during the period. Prevail Innovative Wealth Advisors LLC increased its position in shares of Zoetis by 24.5% in the 1st quarter. Prevail Innovative Wealth Advisors LLC now owns 18,977 shares of the company’s stock valued at $3,211,000 after acquiring an additional 3,738 shares during the period. Finally, Jacobi Capital Management LLC increased its position in shares of Zoetis by 10.9% in the 4th quarter. Jacobi Capital Management LLC now owns 8,040 shares of the company’s stock valued at $1,587,000 after acquiring an additional 788 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

ZTS has been the topic of several research reports. Piper Sandler upped their target price on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Stifel Nicolaus upped their target price on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. BTIG Research upped their target price on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Finally, Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Zoetis presently has an average rating of “Buy” and an average price target of $220.38.

Zoetis Trading Down 1.4 %

ZTS stock opened at $187.28 on Tuesday. The company’s 50-day simple moving average is $187.30 and its 200-day simple moving average is $175.50. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92. The firm has a market cap of $84.85 billion, a P/E ratio of 36.08, a PEG ratio of 2.91 and a beta of 0.89.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. The firm had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. Zoetis’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period last year, the company posted $1.41 EPS. As a group, equities analysts forecast that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.